Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q4 23

Rhea-AI Summary

Stonegate Capital Partners updates coverage on Bio-Path Holdings, Inc. (BPTH) for Q4 2023, providing valuable insights for investors and traders.

Dallas, Texas--(Newsfile Corp. - March 27, 2024) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) for Q4 2023.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

Click image above to view full announcement.

---

About StonegateStonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies.

Contacts:

Stonegate Capital Partners
(214) 987-4121
info@stonegateinc.com

Source: Stonegate, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/203371

FAQ

What is the latest update from Stonegate Capital Partners regarding Bio-Path Holdings, Inc. (BPTH)?

Stonegate Capital Partners has updated its coverage on Bio-Path Holdings, Inc. (BPTH) for Q4 2023.

Where can I find the full announcement from Stonegate Capital Partners about Bio-Path Holdings, Inc. (BPTH)?

You can view the full announcement, including downloadable images, bios, and more, by clicking on the provided link.

What insights does the update from Stonegate Capital Partners offer for investors and traders?

The update from Stonegate Capital Partners provides valuable insights for both investors and traders interested in Bio-Path Holdings, Inc. (BPTH).